Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus (Q36196407)

12 August 2017

Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus (English)

1 reference

12 August 2017

1 reference

Alfred Azenabor

1

1 reference

12 August 2017

Anthonia O Ogbera

series ordinal

2

1 reference

12 August 2017

Ngozi E Adejumo

series ordinal

3

1 reference

12 August 2017

Adejimi O Adejare

series ordinal

4

1 reference

12 August 2017

language of work or name

1 reference

1 October 2011

1 reference

Journal of Research in Medical Sciences

12 August 2017

1 reference

12 August 2017

16

1 reference

12 August 2017

10

1 reference

12 August 2017

1298-1305

1 reference

Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Lipoprotein (a). Heterogeneity and biological relevance

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Glycaemic indices and non-traditional biochemical cardiovascular disease markers in a diabetic population in Nigeria

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Lipoprotein(a) is a potential coronary risk factor

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3430019

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

21 October 2018

1 reference

12 December 2020

An improved colour reagent for the determination of blood glucose by the oxidase system

1 reference

12 December 2020

Further observations on serum viscosity changes in diabetes mellitus

1 reference

12 December 2020

Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus

1 reference

12 December 2020

Acute phase serum proteins in diabetic retinopathy

1 reference

12 December 2020

Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients

1 reference

12 December 2020

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

1 reference

12 December 2020

Serum haptoglobin in juvenile diabetes

1 reference

12 December 2020

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes

1 reference

12 December 2020

Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control

1 reference

12 December 2020

Identifiers

1 reference

12 August 2017

1 reference